Viralgen — an independently operated subsidiary of AskBio (Bayer AG) — is a cell and gene therapy CDMO based in Spain that specializes in AAV production. The company has two state-of-the-art facilities comprising more than 340,000 square feet that provide the cGMP manufacture of AAV products using their proprietary technologies, including their suspension triple-transfection platform. The company’s exclusive focus on AAV allows them to provide expert analysis as well as large-scale production. Viralgen's full offerings range from a proven cell line all the way to QC and release, providing full end-to-end manufacturing development and production service.